Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTC4S | Q16873 | 17/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610616 | 0.85 | PDE4B (0.39) | LTC4SSLC6A3 | |
| SCHEMBL1609145 | 0.84 | TUBB4A (0.43) | SLC6A3KDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL1610619 | 0.83 | PDE4B (0.37) | SLC6A3ALDH1A1 | |
| SCHEMBL1608906 | 0.79 | CRHR1 (0.39) | SLC6A3KDM4EALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL1609829 | 0.79 | TSHR (0.41) | SLC6A3KDM4EALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL1609979 | 0.79 | PDE4B (0.42) | SLC6A3KDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL12712923 | 0.77 | SMN1; SMN2 (0.41) | SMN1; SMN2 | |
| SCHEMBL1609450 | 0.76 | TUBB4A (0.42) | SLC6A3KDM4EALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL1609767 | 0.76 | TUBB4A (0.42) | SLC6A3KDM4EALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL1609112 | 0.76 | SLC6A3 (0.42) | NR1H4SLC6A3KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | DDT, PNPO, CBR3 | LTC4S 3826/4885NR1H4 4330/4885SLC6A3 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.